FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology and can be used to determine the average number of copies of human mitochondrial DNA per cell in various human biological samples, including previously isolated samples of total DNA from human biological materials.
EFFECT: improvement of method for determining average number of copies of human mitochondrial DNA per cell.
1 cl, 5 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| pGEM-TCRAC-sjTREC-sjKREC RECOMBINANT PLASMID DNA CONTAINING NUCLEOTIDE SEQUENCES OF THE T-LYMPHOCYTE Α-RECEPTOR GENE LOCUS AND SIGNAL FRAGMENTS OF THE T- AND B-CELL RECEPTOR EXCISION RINGS | 2022 |
|
RU2807806C1 |
| METHOD FOR QUANTITATIVE ASSESSMENT OF T AND B-LYMPHOCYTES BY CONTENT OF EXCISION RINGS TREC AND KREC IN DNA SAMPLES USING DIGITAL POLYMERASE CHAIN REACTION | 2023 |
|
RU2822204C1 |
| METHOD FOR DETERMINATION OF MTDNA SHARE WITH DELETIONS IN BIOLOGICAL SAMPLES | 2018 |
|
RU2676897C1 |
| MITOCHONDRIAL LOCALIZATION PEPTIDE, NUCLEIC ACID FOR ALLOTOPIC EXPRESSION OF MT-ND4 GENE CONTAINING ITS EXPRESSION VECTOR AND ITS USE | 2023 |
|
RU2817420C1 |
| NUCLEIC ACID FOR ALLOTOPIC EXPRESSION OF MT-ND4 GENE | 2023 |
|
RU2809065C1 |
| METHOD OF PRODUCING FULL-LENGTH HUMAN MITOCHONDRIAL DNA SEQUENCE USING SET OF OLIGONUCLEOTIDES BY MULTIPLEX AMPLIFICATION FOR WORKING WITH DEGRADED DNA SAMPLES | 2021 |
|
RU2818323C2 |
| TREATMENT OF MITOCHONDRIAL DISEASES | 2016 |
|
RU2745611C2 |
| METHOD FOR CORRECTION OF MITOCHONDRIAL DYSFUNCTION BY GENETIC CONSTRUCT | 2016 |
|
RU2642972C1 |
| METHOD FOR PREDICTION OF METASTASES DEVELOPMENT IN PATIENTS WITH GASTRIC CANCER | 2016 |
|
RU2624505C1 |
| TEST SYSTEM “HV2 mtDNA-PCR” FOR PREDICTING THE DEVELOPMENT OF METASTASES IN PATIENTS WITH GASTRIC CANCER | 2017 |
|
RU2683571C1 |
